Limited genetic screening of a small number of HL-associated genes (GJB2, SLC26A4, and MT-RNR1) to improve the detection of late-onset prelingual HL was first proposed in 2006.2 Afterwards, concurrent limited genetic screening and hearing screening programs have been evaluated in several cities and provinces.10,12,14,15,16,17,18 The results show that limited genetic screening can identify newborns who otherwise might be missed by hearing screening alone and may identify individuals at risk for late-onset HL. The gene discussed is SLC26A4; the disease is Hodgkins lymphoma.